There is only ONE phase 3 trial , 'supposedly" going forward, and funded by another company. THAT company (3SBio) is also going into HIDING after management is taking it private., ------SO WHO REALLY KNOWS ABOUT FUTURE PLANS . The other trial , funded by ILJIN , was cancelled in January 2012, when ISA cancelled the agreement.-----the reason for the arbitration proceedings. Can't really classify the LUX trial as phase 3, since it is more of a supplimentary trial demanded by the FDA to support previous , 'unresolved' data from ISA trials, LUX had put forward with their applicaiton. So ISA is more the stuff that comes out of a dog's rear, than the dog itself!